What are the recent financial highlights of EPIGRAL LIMITED?

EPIGRAL LIMITED recently reported a total revenue of ₹2,447.13 Cr and a net profit margin of 14.22%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of EPIGRAL LIMITED?

EPIGRAL LIMITED offers a dividend yield of 0.42%, with a dividend rate of ₹7.5 per share.

What are the key financial metrics of EPIGRAL LIMITED?

Key financial metrics include a trailing P/E ratio of 20.177433, forward P/E of 17.399897, book value of ₹337.005, price-to-book ratio of 4.977226, and a market capitalization of ₹72.36 billion.

What does EPIGRAL LIMITED do?

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda, chlorine, hydrogen, and caustic potash products. It also engages in the trading of agrochemical products. It serves various sectors, including CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Epigral

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Epigral

Latest updates related to Epigral

Sr No.	Title	Sentiment
1	Stocks to buy in 2025: Epigral, Coforge among top 5 stocks that could give 18-37% return in 1 year The Economic Times	🔄
2	Stocks to buy in May: Nirmal Bang suggests Epigral and Suryoday Small Finance Bank – here’s why Mint	🔄
3	Stocks to buy in 2025: Epigral, Coforge among top 5 stocks that could give 18-37% return in 1 year The Economic Times	🔄
4	Epigral edges higher after Crisil Ratings upgrades ratings to 'AA' with 'stable' outlook Business Standard	🔄
5	Epigral's Stock Surge Highlights Divergence from Broader Market Trends MarketsMojo	🔄
6	Epigral targets 20% annual growth, expects to more than double revenue by FY28 BusinessLine	🔄
7	Multibagger Stock: Epigral yields 120% return in a year, 430% in over 3 years Mint	🔄
8	CRISIL revises' Epigral’s outlook to positive Indian Chemical News	🔄
9	Epigral Consolidated December 2024 Net Sales at Rs 645.24 crore, up 36.84% Y-o-Y Moneycontrol	🔄
10	Epigral Q3 result: PAT more than doubles to Rs 103.63 cr, shares up 5.57% Business Standard	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

ISGEC CONCOR CCHHL TNTELE RANEHOLDIN BBOX COSMOFIRST CORDSCABLE PODDARHOUS AMIORG